CFVLX
Price
$32.49
Change
+$0.08 (+0.25%)
Updated
Dec 26 closing price
RMEBX
Price
$55.80
Change
+$0.07 (+0.13%)
Updated
Dec 26 closing price
Ad is loading...

CFVLX vs RMEBX

Header iconCFVLX vs RMEBX Comparison
Open Charts CFVLX vs RMEBXBanner chart's image
Commerce Value
Price$32.49
Change+$0.08 (+0.25%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R2E
Price$55.80
Change+$0.07 (+0.13%)
VolumeN/A
CapitalizationN/A
CFVLX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CFVLX vs. RMEBX commentary
Dec 27, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CFVLX is a Buy and RMEBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 103B vs. CFVLX (258M). CFVLX pays higher dividends than RMEBX: CFVLX (2.37) vs RMEBX (1.54). CFVLX was incepted earlier than RMEBX: CFVLX (28 years) vs RMEBX (10 years). CFVLX is a more actively managed with annual turnover of: 46.00 vs. RMEBX (25.00). RMEBX has a lower initial minimum investment than CFVLX: RMEBX (250) vs CFVLX (1000). RMEBX annual gain was more profitable for investors over the last year : 11.90 vs. CFVLX (7.16). RMEBX return over 5 years is better than : 38.18 vs. CFVLX (15.13).
CFVLXRMEBXCFVLX / RMEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years10 years-
Gain YTD6.46911.15358%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets258M103B0%
Annual Yield % from dividends2.371.54154%
Returns for 1 year7.1611.9060%
Returns for 3 years-1.2511.77-11%
Returns for 5 years15.1338.1840%
Returns for 10 years22.4358.9938%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRNS0.260.02
+8.07%
Marinus Pharmaceuticals
EXPD111.190.69
+0.62%
Expeditors International of Washington
PRTA15.400.07
+0.46%
Prothena Corp
FATE1.66N/A
N/A
Fate Therapeutics
RNG36.99-0.36
-0.96%
RINGCENTRAL